https://onkure.comocreative.com/news/press-releases/ 2024-11-12T02:25:17+00:00 https://onkure.comocreative.com/onkure-therapeutics-appoints-nicholas-a-saccomano-ph-d-to-its-board-of-directors/ 2022-01-18T14:26:21+00:00 https://onkure.comocreative.com/onkure-therapeutics-announces-positive-topline-first-in-human-phase-1-results-for-oki-179/ 2022-02-03T19:13:35+00:00 https://onkure.comocreative.com/onkure-close-7m-series-a-financing-to-support-development-of-epigenetics-drug/ 2022-02-07T17:49:50+00:00 https://onkure.comocreative.com/onkure-announces-fda-ind-regulatory-clearance-to-start-phase-1-trials-for-oki-179/ 2022-02-07T17:52:49+00:00 https://onkure.comocreative.com/onkure-and-cu-cancer-center-announce-first-patient-enrolled-in-clinical-trial-of-oki-179-a-potent-and-selective-hdac-inhibitor/ 2022-02-07T17:59:00+00:00 https://onkure.comocreative.com/onkure-expands-executive-team-and-appoints-head-of-discovery-chief-financial-officer-and-general-counsel/ 2022-02-07T18:01:19+00:00 https://onkure.comocreative.com/onkure-and-pfizer-enter-clinical-trial-collaboration-and-supply-agreement-to-evaluate-combination-of-oki-179-and-binimetinib/ 2022-02-07T18:03:37+00:00 https://onkure.comocreative.com/onkure-inc-raises-55-million-series-b-financing/ 2022-02-07T18:06:47+00:00 https://onkure.comocreative.com/onkure-builds-its-discovery-team-and-appoints-heads-of-computational-drug-discovery-and-pharmacology/ 2022-02-07T18:09:33+00:00 https://onkure.comocreative.com/onkure-expands-executive-team-and-appoints-head-of-discovery-chief-financial-officer-and-general-counsel-2/ 2022-02-07T18:11:21+00:00 https://onkure.comocreative.com/onkure-therapeutics-appoints-jennifer-r-diamond-m-d-as-chief-medical-officer/ 2022-02-07T18:13:54+00:00 https://onkure.comocreative.com/onkure-therapeutics-appoints-mark-l-boys-ph-d-as-vice-president-of-discovery-chemistry/ 2022-02-07T18:17:39+00:00 https://onkure.comocreative.com/onkure-therapeutics-appoints-jason-leverone-cpa-as-chief-financial-officer/ 2022-02-08T12:01:16+00:00 https://onkure.comocreative.com/onkure-therapeutics-to-present-late-breaking-preclinical-data-on-oki-179-at-the-aacr-annual-meeting-2022/ 2022-03-08T21:30:23+00:00 https://onkure.comocreative.com/681/ 2022-05-10T17:48:53+00:00 https://onkure.comocreative.com/onkure-therapeutics-appoints-kevin-s-litwiler-ph-d-as-senior-vice-president-of-dmpk-and-clinical-pharmacology/ 2022-06-21T15:07:44+00:00 https://onkure.comocreative.com/onkure-therapeutics-announces-promising-preclinical-data-on-oki-179-in-ras-mutated-tumor-models-presented-in-a-late-breaking-session-at-aacr/ 2022-07-06T17:50:22+00:00 https://onkure.comocreative.com/onkure-therapeutics-announces-first-patient-dosed-in-the-phase-1b-2-nautilus-trial-of-oki-179-in-combination-with-binimetinib-in-patients-with-advanced-nras-mutated-melanoma/ 2022-08-23T16:51:13+00:00 https://onkure.comocreative.com/onkure-therapeutics-appoints-robbie-alton-pharm-as-vice-president-of-clinical-operations/ 2022-12-06T12:00:10+00:00 https://onkure.comocreative.com/onkure-therapeutics-announces-54-million-series-c-financing/ 2023-05-23T09:00:37+00:00 https://onkure.comocreative.com/onkure-therapeutics-appoints-ann-howell-pharm-d-as-vice-president-of-regulatory-affairs/ 2023-09-20T12:41:10+00:00 https://onkure.comocreative.com/onkure-announces-ind-clearance-by-u-s-fda-enabling-phase-1-initiation-for-its-mutant-selective-pi3k%ef%81%a1-inhibitor-oki-219/ 2024-01-10T18:21:58+00:00 https://onkure.comocreative.com/onkure-announces-the-appointment-of-samuel-agresta-m-d-as-chief-medical-officer/ 2024-02-15T14:40:28+00:00 https://onkure.comocreative.com/reneo-pharmaceuticals-and-onkure-announce-proposed-merger/ 2024-05-13T11:36:49+00:00 https://onkure.comocreative.com/onkure-announces-the-appointment-of-rogan-nunn-j-d-as-general-counsel-and-secretary/ 2024-10-07T12:39:17+00:00 https://onkure.comocreative.com/onkure-announces-the-appointment-of-dylan-hartley-ph-d-as-chief-scientific-officer/ 2024-10-07T12:46:41+00:00 https://onkure.comocreative.com/https-investors-onkuretherapeutics-com-n/ 2024-10-07T12:58:15+00:00 https://onkure.comocreative.com/onkure-to-present-clinical-and-preclinical-data-for-oki-219-at-the-2024-san-antonio-breast-cancer-symposium/ 2024-11-12T02:24:15+00:00 https://onkure.comocreative.com/onkure-to-present-at-the-stifel-2024-healthcare-conference/ 2024-11-12T02:25:17+00:00